vs
Protalix BioTherapeutics, Inc.（PLX）与STRATUS PROPERTIES INC（STRS）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是STRATUS PROPERTIES INC的1.1倍（$9.1M vs $8.3M），STRATUS PROPERTIES INC净利率更高（203.2% vs -60.3%，领先263.6%），STRATUS PROPERTIES INC同比增速更快（-19.4% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-38.0M），过去两年Protalix BioTherapeutics, Inc.的营收复合增速更高（-6.7% vs -44.1%）
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
该企业是一家涵盖酒店、度假村、娱乐与传媒业务的综合性公司，名称源自其旗下资产——位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司发展可追溯至爱德华·盖洛德旗下俄克拉荷马出版公司的子公司时期，1983年收购WSM公司后奠定了现代企业的业务基础，借此获得了大奥普里等知名相关资产。
PLX vs STRS — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.1M | $8.3M |
| 净利润 | $-5.5M | $16.9M |
| 毛利率 | 49.4% | — |
| 营业利润率 | -51.1% | — |
| 净利率 | -60.3% | 203.2% |
| 营收同比 | -49.9% | -19.4% |
| 净利润同比 | -184.8% | 1293.4% |
| 每股收益（稀释后） | $-0.06 | $2.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $9.1M | $8.3M | ||
| Q3 25 | $17.9M | $5.0M | ||
| Q2 25 | $15.7M | $11.6M | ||
| Q1 25 | $10.1M | $5.0M | ||
| Q4 24 | $18.2M | $10.3M | ||
| Q3 24 | $18.0M | $8.9M | ||
| Q2 24 | $13.5M | $8.5M | ||
| Q1 24 | — | $26.5M |
| Q4 25 | $-5.5M | $16.9M | ||
| Q3 25 | $2.4M | $-8.0M | ||
| Q2 25 | $164.0K | $-2.3M | ||
| Q1 25 | $-3.6M | $-3.8M | ||
| Q4 24 | $6.5M | $-1.4M | ||
| Q3 24 | $3.2M | $-1.4M | ||
| Q2 24 | $-2.2M | $-2.8M | ||
| Q1 24 | — | $3.7M |
| Q4 25 | 49.4% | — | ||
| Q3 25 | 53.4% | -85.1% | ||
| Q2 25 | 62.5% | -19.0% | ||
| Q1 25 | 19.1% | 5.1% | ||
| Q4 24 | 78.7% | 18.3% | ||
| Q3 24 | 53.4% | 2.5% | ||
| Q2 24 | 29.8% | 10.9% | ||
| Q1 24 | — | 30.7% |
| Q4 25 | -51.1% | — | ||
| Q3 25 | 11.9% | -162.9% | ||
| Q2 25 | 7.5% | -6.5% | ||
| Q1 25 | -41.0% | -71.3% | ||
| Q4 24 | 39.6% | -13.6% | ||
| Q3 24 | 22.2% | -17.1% | ||
| Q2 24 | -18.0% | -34.4% | ||
| Q1 24 | — | 13.9% |
| Q4 25 | -60.3% | 203.2% | ||
| Q3 25 | 13.2% | -161.1% | ||
| Q2 25 | 1.0% | -19.8% | ||
| Q1 25 | -35.8% | -74.5% | ||
| Q4 24 | 35.6% | -13.7% | ||
| Q3 24 | 18.0% | -15.9% | ||
| Q2 24 | -16.4% | -32.7% | ||
| Q1 24 | — | 13.9% |
| Q4 25 | $-0.06 | $2.42 | ||
| Q3 25 | $0.03 | $-0.62 | ||
| Q2 25 | $0.00 | $0.03 | ||
| Q1 25 | $-0.05 | $-0.36 | ||
| Q4 24 | $0.10 | $-0.06 | ||
| Q3 24 | $0.03 | $-0.05 | ||
| Q2 24 | $-0.03 | $-0.21 | ||
| Q1 24 | — | $0.56 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.7M | $74.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $48.2M | $204.5M |
| 总资产 | $82.3M | $563.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $14.7M | $74.3M | ||
| Q3 25 | $13.6M | $55.0M | ||
| Q2 25 | $17.9M | $59.4M | ||
| Q1 25 | $19.5M | $12.0M | ||
| Q4 24 | $19.8M | $20.2M | ||
| Q3 24 | $27.4M | $19.6M | ||
| Q2 24 | $23.4M | $13.5M | ||
| Q1 24 | — | $20.7M |
| Q4 25 | $48.2M | $204.5M | ||
| Q3 25 | $52.9M | $185.8M | ||
| Q2 25 | $49.9M | $191.9M | ||
| Q1 25 | $45.2M | $191.5M | ||
| Q4 24 | $43.2M | $194.7M | ||
| Q3 24 | $32.4M | $196.4M | ||
| Q2 24 | $28.6M | $196.3M | ||
| Q1 24 | — | $197.6M |
| Q4 25 | $82.3M | $563.4M | ||
| Q3 25 | $82.3M | $572.6M | ||
| Q2 25 | $78.5M | $574.8M | ||
| Q1 25 | $73.9M | $534.6M | ||
| Q4 24 | $73.4M | $532.6M | ||
| Q3 24 | $61.6M | $523.2M | ||
| Q2 24 | $91.5M | $514.0M | ||
| Q1 24 | — | $509.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.0M | $-29.9M |
| 自由现金流经营现金流 - 资本支出 | $1.6M | $-38.0M |
| 自由现金流率自由现金流/营收 | 17.8% | -458.5% |
| 资本支出强度资本支出/营收 | 4.4% | 98.2% |
| 现金转化率经营现金流/净利润 | — | -1.77× |
| 过去12个月自由现金流最近4个季度 | $-13.6M | $-70.3M |
8季度趋势，按日历期对齐
| Q4 25 | $2.0M | $-29.9M | ||
| Q3 25 | $-3.7M | $-9.0M | ||
| Q2 25 | $-5.2M | $-1.7M | ||
| Q1 25 | $-5.1M | $-13.5M | ||
| Q4 24 | $4.0M | $-5.8M | ||
| Q3 24 | $4.1M | $-686.0K | ||
| Q2 24 | $-3.6M | $-8.3M | ||
| Q1 24 | — | $6.5M |
| Q4 25 | $1.6M | $-38.0M | ||
| Q3 25 | $-4.2M | $-9.9M | ||
| Q2 25 | $-5.7M | $-4.3M | ||
| Q1 25 | $-5.4M | $-18.0M | ||
| Q4 24 | $3.6M | $-35.0M | ||
| Q3 24 | $4.0M | $-7.5M | ||
| Q2 24 | $-3.8M | $-16.3M | ||
| Q1 24 | — | $-1.6M |
| Q4 25 | 17.8% | -458.5% | ||
| Q3 25 | -23.7% | -198.7% | ||
| Q2 25 | -36.2% | -37.2% | ||
| Q1 25 | -53.0% | -357.4% | ||
| Q4 24 | 19.6% | -339.7% | ||
| Q3 24 | 22.4% | -84.4% | ||
| Q2 24 | -28.1% | -191.6% | ||
| Q1 24 | — | -6.0% |
| Q4 25 | 4.4% | 98.2% | ||
| Q3 25 | 2.8% | 18.4% | ||
| Q2 25 | 2.8% | 22.7% | ||
| Q1 25 | 3.0% | 89.8% | ||
| Q4 24 | 2.3% | 283.0% | ||
| Q3 24 | 0.5% | 76.7% | ||
| Q2 24 | 1.3% | 94.2% | ||
| Q1 24 | — | 30.7% |
| Q4 25 | — | -1.77× | ||
| Q3 25 | -1.58× | — | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
STRS
暂无分部数据
